240 filings
Page 3 of 12
8-K
1l2hnq
1 Nov 22
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
4:05pm
8-K
05fq37x6q6a879c13 qt
27 Oct 22
CRISPR Therapeutics Announces Planned Transition of Chief Operating Officer
8:36am
8-K
e72isr ns49plnhb
27 Sep 22
Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022
7:48am
S-8
ocyb5yvk1 zd3u
8 Aug 22
Registration of securities for employees
4:06pm
8-K
ztf972w r24f8nz8h
8 Aug 22
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
8:05am
CORRESP
ml5et4
23 Jun 22
Correspondence with SEC
12:00am
8-K
xok17yn9 dfy0mfnv4l
21 Jun 22
Other Events
5:05pm
8-K
zj2d71
13 Jun 22
Departure of Directors or Certain Officers
4:58pm
8-K
kdwke
13 Jun 22
Regulation FD Disclosure
8:02am
UPLOAD
m5c91dzbj3v2w46urq
13 Jun 22
Letter from SEC
12:00am
8-K
w1xjv7t0
16 May 22
CRISPR Therapeutics Announces the Appointment of Phuong Khanh Morrow, M.D., FACP, as Chief Medical Officer
4:14pm
8-K
7aw0d41idwbiwdsmrns
12 May 22
Regulation FD Disclosure
4:05pm
8-K
kqygorqwekpv7k up5
9 May 22
Results of Operations and Financial Condition
4:06pm
DEFA14A
ueuei2dcq5unm22da
25 Apr 22
Additional proxy soliciting materials
4:27pm
8-K
ou6lu8gup o4ko
15 Feb 22
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm